Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant
Clinical trial NCT00388999 · COMPLETED
Trial details
- NCT number
- NCT00388999
- Sponsor
- Enzon Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2009-02-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.